A no-cost testing method to prevent the onset of Alzheimer’s disease is coming to Central New York.
“Gene Match” uses cheek swab tests from people between the ages of 55 and 75 without memory loss.
Those who are eligible would join the registry to support Alzheimer’s clinical trials.
The Director of Clarity Clinical research tells us the goal of Gene Match is prevention — tackling the disease before it starts.
“When we look at prevention and research, what we’re looking at is identifying people at risk who haven’t developed symptoms of memory loss and people who really for all intents and purposes could very well develop it down the road anywhere from five to 10 years,” said Lisa Sonneborn, of Clarity Clinical Research.
Researchers say a breakthrough treatment to delay the onset by any number of years could reduce the number of those diagnosed by millions in the U.S.